Press releases

6
Mar 2017
21:30 E.S.T.

Cellectis Reports 4th Quarter and Full Year 2016 Financial Results

Read more
7
Feb 2017
21:30 E.S.T.

Cellectis to Present at the LEERINK Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017 at 1:30pm ET in New York

Read more
6
Feb 2017
21:30 E.S.T.

FDA Grants Cellectis IND Approval to Proceed with the Clinical Development of UCART123, the First Gene Edited Off-the-Shelf CAR T-Cell Product Candidate developed in the U.S.

Read more
23
Jan 2017
21:30 E.S.T.

Cellectis Studies Safety in New CAR Architecture Controlling CAR T-Cell Functions

Read more
23
Jan 2017
21:30 E.S.T.

Four Prominent Physicians to Join Cellectis Clinical Advisory Board

Read more
4
Jan 2017
21:30 E.S.T.

Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT

Read more
3
Jan 2017
21:30 E.S.T.

Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US